These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Effects of Fas ligand expression on pancreatic islet allografts]. Cai S; Zhan W; He Y Zhonghua Wai Ke Za Zhi; 2001 Aug; 39(8):634-7. PubMed ID: 11758207 [TBL] [Abstract][Full Text] [Related]
6. Effect of liver transplantation on islet allografts: up-regulation of Fas ligand and apoptosis of T lymphocytes are associated with islet graft tolerance. Wang XY; Sun J; Wang C; France M; Sheil AG Transplantation; 2001 Jan; 71(1):102-11. PubMed ID: 11211174 [TBL] [Abstract][Full Text] [Related]
7. Immune response and myoblasts that express Fas ligand. Kang SM; Hoffmann A; Le D; Springer ML; Stock PG; Blau HM Science; 1997 Nov; 278(5341):1322-4. PubMed ID: 9411754 [No Abstract] [Full Text] [Related]
8. Acceptance of islet allografts transplanted with Fas ligand expressing testicular allografts. Takeda Y; Gotoh M; Dono K; Grochowiecki TR; Kimura F; Okuyama M; Shimizu J; Nagano H; Umeshita K; Sakon M; Miyasaka M; Monden M Transplant Proc; 1999; 31(1-2):624. PubMed ID: 10083266 [No Abstract] [Full Text] [Related]
9. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts. Djamali A; Odorico JS Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278 [TBL] [Abstract][Full Text] [Related]
11. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice. Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475 [TBL] [Abstract][Full Text] [Related]
12. Immunomodulation with SA-FasL protein as an effective means of preventing islet allograft rejection in chemically diabetic NOD mice. Yolcu ES; Zhao H; Shirwan H Transplant Proc; 2013 Jun; 45(5):1889-91. PubMed ID: 23769064 [TBL] [Abstract][Full Text] [Related]
13. Immunoprotection and Functional Improvement of Allogeneic Islets in Diabetic Mice, Using a Stable Indoleamine 2,3-Dioxygenase Producing Scaffold. Hosseini-Tabatabaei A; Jalili RB; Khosravi-Maharlooei M; Hartwell R; Kilani RT; Zhang Y; Ghahary A Transplantation; 2015 Jul; 99(7):1341-8. PubMed ID: 25769070 [TBL] [Abstract][Full Text] [Related]
14. The effect of FasL expression on pancreatic islet allografts. Zhan W; Cai S; Wang J; He Y; Zheng Z; Peng J Chin Med J (Engl); 2002 Jul; 115(7):1006-9. PubMed ID: 12150731 [TBL] [Abstract][Full Text] [Related]
15. Pancreatic islets engineered with SA-FasL protein establish robust localized tolerance by inducing regulatory T cells in mice. Yolcu ES; Zhao H; Bandura-Morgan L; Lacelle C; Woodward KB; Askenasy N; Shirwan H J Immunol; 2011 Dec; 187(11):5901-9. PubMed ID: 22068235 [TBL] [Abstract][Full Text] [Related]
16. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival. Min WP; Gorczynski R; Huang XY; Kushida M; Kim P; Obataki M; Lei J; Suri RM; Cattral MS J Immunol; 2000 Jan; 164(1):161-7. PubMed ID: 10605007 [TBL] [Abstract][Full Text] [Related]
17. Multiple donor allotransplantation. A new approach to pancreatic islet transplantation. Gotoh M; Porter J; Kanai T; Monaco AP; Maki T Transplantation; 1988 Jun; 45(6):1008-12. PubMed ID: 3132760 [TBL] [Abstract][Full Text] [Related]
18. [Synergistic protective effect of testicular cells expressing Fas ligand and cyclosporine A on the survival of islet allografts]. Chen CQ; Zhan WH; Wang JP; Cai SR; He D; Wu XJ; Lan P Zhonghua Wai Ke Za Zhi; 2003 Nov; 41(11):845-8. PubMed ID: 14703462 [TBL] [Abstract][Full Text] [Related]